Latest
The RBM Partnership to End Malaria welcomes the announcement today of a major project by kENUP Foundation and BioNTech to develop the first mRNA-based prophylactic malaria vaccine. Supported by the World Health Organization (WHO), the Africa Centres for Disease Control and Prevention, the European Commission and European Investment Bank, and international partners, the project aims to use […]
...Pledge comes as researchers and programme delivery experts come together to celebrate Medicines for Malaria Venture’s 20th anniversary Today, country leaders, public health experts, scientists and researchers join Medicines for Malaria Venture (MMV) to mark 20 years of innovation in malaria medicines and look ahead to the next generation of interventions for what remains one of the world’s deadliest […]
...